Dr. Beth Ann Martin, MD

Dr. Martin practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Martin's NPI, 1134154420, was assigned on July 12, 2006. Dr. Martin graduated from Icahn School Of Medicine At Mount Sinai in 1987. Dr. Martin's California license number on file is G64813.

Dr. Martin's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Martin's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Martin to 1 more hospital, named with a free account. Dr. Martin's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Martin practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Martin's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dr. Martin is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Martin's licenses on file in 2 states: California and Wyoming.

Dmand AI lists chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, lymphoma, multiple myeloma, neutropenia and purpura and thrombocytopenia among the conditions Dr. Martin treats.

CMS data shows 512 Medicare services from Dr. Martin across 9 procedure codes in 2024, for 214 Medicare patients. Medicare paid $49,081 for them.

CMS counts 214 Medicare patients who saw Dr. Martin in 2024. The largest group is 75 to 84, with 78 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 32% are also on Medicaid. Their average risk score is 2.80, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Martin's median patient age at 52, with 58% women.

In 2024, Dr. Martin wrote 203 Medicare Part D claims for 32 patients. 67% of them were for generic drugs. CMS names the drug for 42 of them, across 3 drugs with 11 or more claims each, at $32,073 in total drug cost. In 2022, CMS named 26 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Martin for performance year 2024, reported as part of a group. Dr. Martin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Martin as offering telehealth.

Dmand AI links 16 papers to Dr. Martin, published from 2014 to 2025. 2014 was the busiest year, with 2. The most frequent topics are Antibodies, Monoclonal, Bone Marrow Transplantation and Lymphohistiocytosis, Hemophagocytic. Dr. Martin has published most often in Bone Marrow Transplant. Dr. Martin's most frequent co-authors are Jane L. Liesveld, MD, Ryanne A. Brown, MD and John F. Dipersio, MD.

CMS Open Payments shows 6 general payments to Dr. Martin from 2 drug and device companies from 2018 to 2020. Consulting fees make up the largest share, 65% of the total. Genentech, Inc. paid the most, $24,928.

Dr. Martin graduated from Icahn School Of Medicine At Mount Sinai in 1987.

Dr. Martin is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 4. Check the plan with the practice before a visit.